RCUS

Arcus Biosciences, Inc.

Name: Arcus Biosciences, Inc. insider trading (SEC Form 4) history
Creator: U.S. Securities and Exchange Commission

SEC CIK 1724521

$23.80 +13.4% · 90 days

90-day buys

0 open-market

90-day sells

$265K

2 open-market

Net insider flow

−$265K

Net selling

Filings shown

Most recent

At a glance

Over the last 90 days, insiders at RCUS have sold a net $265K of stock (0 open-market buys vs 2 sells).

Largest recent trade: Jaen Juan C. sold $2.05M of RCUS, trimming their stake 8%.

Most active filer: Rosen Terry J, with 42 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for RCUS, newest first

View on SEC EDGAR ↗

RCUS

Arcus Biosciences, Inc.

Sell Azoy Alexander · Chief Accounting Officer · Open-market sale · filed 2w ago ΔOwn −6.1%

Azoy Alexander sold $66K of RCUS, trimming their stake 6%.

−$66K

2,562 sh @ $26

RCUS

Arcus Biosciences, Inc.

Sell Goeltz II Robert C. · Chief Financial Officer · Open-market sale · filed May 12, 2026 ΔOwn −8.4%

Goeltz Ii Robert C. sold $199K of RCUS, trimming their stake 8%.

−$199K

7,763 sh @ $26

RCUS

Arcus Biosciences, Inc.

Grant/award Markus Richard · Chief Medical Officer · Grant/award · filed Jan 26, 2026 ΔOwn +37%

+$0

24,000 sh

RCUS

Arcus Biosciences, Inc.

Grant/award ROSEN TERRY J · Director, Chief Executive Officer · Grant/award · filed Jan 26, 2026 ΔOwn +3.7%

+$0

79,000 sh

RCUS

Arcus Biosciences, Inc.

Grant/award Jaen Juan C. · President · Grant/award · filed Jan 26, 2026 ΔOwn +9.0%

+$0

31,000 sh

RCUS

Arcus Biosciences, Inc.

Grant/award Tang Carolyn C. · General Counsel · Grant/award · filed Jan 26, 2026 ΔOwn +19%

+$0

24,000 sh

RCUS

Arcus Biosciences, Inc.

Grant/award Goeltz II Robert C. · Chief Financial Officer · Grant/award · filed Jan 26, 2026 ΔOwn +35%

+$0

24,000 sh

RCUS

Arcus Biosciences, Inc.

Grant/award Azoy Alexander · Chief Accounting Officer · Grant/award · filed Jan 26, 2026 ΔOwn +114%

+$0

21,050 sh

RCUS

Arcus Biosciences, Inc.

Grant/award Jarrett Jennifer · Chief Operating Officer · Grant/award · filed Jan 26, 2026 ΔOwn +16%

+$0

31,000 sh

RCUS

Arcus Biosciences, Inc.

Gift ROSEN TERRY J · Director, Chief Executive Officer · Gift · filed Jan 9, 2026 ΔOwn −1.6%

−$0

35,000 sh

RCUS

Arcus Biosciences, Inc.

Sell Jaen Juan C. · President · Open-market sale · filed Jan 7, 2026 ΔOwn −3.1%

Jaen Juan C. sold $633.2K of RCUS, trimming their stake 3%.

−$633.2K

29,670 sh @ $21

RCUS

Arcus Biosciences, Inc.

Sell Jaen Juan C. · President · Open-market sale · filed Jan 7, 2026 ΔOwn −0.2%

Jaen Juan C. sold $45.9K of RCUS.

−$45.9K

2,053 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Jaen Juan C. · President · Open-market sale · filed Jan 7, 2026

Jaen Juan C. sold $2.3K of RCUS.

−$2.3K

100 sh @ $23

RCUS

Arcus Biosciences, Inc.

Sell Goeltz II Robert C. · Chief Financial Officer · Open-market sale · filed Jan 2, 2026 ΔOwn −8.8%

Goeltz Ii Robert C. sold $153.2K of RCUS, trimming their stake 9%.

−$153.2K

6,552 sh @ $23

RCUS

Arcus Biosciences, Inc.

Gift ROSEN TERRY J · Director, Chief Executive Officer · Gift · filed Jan 2, 2026 ΔOwn −0.1%

−$0

2,400 sh

RCUS

Arcus Biosciences, Inc.

Sell Azoy Alexander · Chief Accounting Officer · Open-market sale · filed Dec 18, 2025 ΔOwn −19%

Azoy Alexander sold $96.6K of RCUS, trimming their stake 19%.

−$96.6K

4,343 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Tang Carolyn C. · General Counsel · Open-market sale · filed Dec 18, 2025 ΔOwn −5.2%

Tang Carolyn C. sold $150.9K of RCUS, trimming their stake 5%.

−$150.9K

6,810 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Markus Richard · Chief Medical Officer · Open-market sale · filed Dec 18, 2025 ΔOwn −6.4%

Markus Richard sold $99.6K of RCUS, trimming their stake 6%.

−$99.6K

4,494 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Azoy Alexander · Chief Accounting Officer · Open-market sale · filed Dec 18, 2025 ΔOwn −8.5%

Azoy Alexander sold $46.8K of RCUS, trimming their stake 8%.

−$46.8K

2,113 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Goeltz II Robert C. · Chief Financial Officer · Open-market sale · filed Dec 18, 2025 ΔOwn −7.4%

Goeltz Ii Robert C. sold $132.1K of RCUS, trimming their stake 7%.

−$132.1K

5,960 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Jarrett Jennifer · Chief Operating Officer · Open-market sale · filed Dec 18, 2025 ΔOwn −4.9%

Jarrett Jennifer sold $221.2K of RCUS, trimming their stake 5%.

−$221.2K

9,983 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Jaen Juan C. · President · Open-market sale · filed Dec 18, 2025 ΔOwn −2.8%

Jaen Juan C. sold $221.2K of RCUS, trimming their stake 3%.

−$221.2K

9,983 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell ROSEN TERRY J · Director, Chief Executive Officer · Open-market sale · filed Dec 18, 2025 ΔOwn −1.2%

Rosen Terry J sold $570.5K of RCUS, trimming their stake 1%.

−$570.5K

25,744 sh @ $22

RCUS

Arcus Biosciences, Inc.

Gift Ribas Antoni · Director · Gift · filed May 12, 2026 ΔOwn −12%

−$0

5,050 sh

RCUS

Arcus Biosciences, Inc.

Sell Tang Carolyn C. · General Counsel · Open-market sale · filed Dec 18, 2025 ΔOwn −5.5%

Tang Carolyn C. sold $167.6K of RCUS, trimming their stake 6%.

−$167.6K

7,658 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Markus Richard · Chief Medical Officer · Open-market sale · filed Dec 18, 2025 ΔOwn −6.7%

Markus Richard sold $110.6K of RCUS, trimming their stake 7%.

−$110.6K

5,052 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Azoy Alexander · Chief Accounting Officer · Open-market sale · filed Dec 18, 2025 ΔOwn −8.7%

Azoy Alexander sold $52K of RCUS, trimming their stake 9%.

−$52K

2,376 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Goeltz II Robert C. · Chief Financial Officer · Open-market sale · filed Dec 18, 2025 ΔOwn −7.7%

Goeltz Ii Robert C. sold $146.7K of RCUS, trimming their stake 8%.

−$146.7K

6,702 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Jarrett Jennifer · Chief Operating Officer · Open-market sale · filed Dec 18, 2025 ΔOwn −5.2%

Jarrett Jennifer sold $245.7K of RCUS, trimming their stake 5%.

−$245.7K

11,225 sh @ $22

RCUS

Arcus Biosciences, Inc.

Sell Jaen Juan C. · President · Open-market sale · filed Dec 18, 2025 ΔOwn −3.1%

Jaen Juan C. sold $245.7K of RCUS, trimming their stake 3%.

−$245.7K

11,225 sh @ $22

About RCUS insider activity

This page tracks every recent Form 4 filed for Arcus Biosciences, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is RCUS insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Arcus Biosciences, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.